Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

$1.30
+0.58 (+80.56%)
(As of 04/26/2024 ET)

Recent Biodexa Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/26/2024
7:45 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:19 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:24 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/27/2024
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
03/28/2024
5:00 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
03/18/2024
3:31 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
02/28/2024
3:14 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
02/28/2024
3:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
02/28/2024
3:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
02/23/2024
12:25 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:47 PM
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Ionic Ventures, LLC (Filed by)
Form SC 13G/A
02/14/2024
1:42 PM
ARMISTICE CAPITAL, LLC (Filed by)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
1:14 PM
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G/A
02/12/2024
3:30 PM
Bigger Capital, LLC (Filed by)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Form SC 13G
01/22/2024
7:51 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/29/2023
11:10 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/28/2023
3:30 PM
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Biodexa Pharmaceuticals Plc (Subject)
Biodexa Pharmaceuticals (Subject)
Cavalry Fund I LP (Filed by)
Form SC 13G
12/26/2023
3:51 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/26/2023
3:53 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/26/2023
3:53 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/21/2023
3:30 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
3:54 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B4
12/18/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
12/14/2023
4:20 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1/A
12/06/2023
4:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1/A
12/06/2023
3:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/27/2023
7:57 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1/A
11/27/2023
7:45 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2023
3:06 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
10/03/2023
9:10 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/29/2023
3:45 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2023
3:23 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/24/2023
3:21 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/24/2023
3:22 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/24/2023
7:07 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2023
7:27 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2023
3:43 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2023
10:52 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/26/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/22/2023
3:33 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad)

This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?

Click Here To Get Your Free Copy
06/20/2023
3:30 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
06/20/2023
7:16 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2023
7:41 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/15/2023
3:51 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2023
7:35 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
11:15 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/02/2023
5:00 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/01/2023
6:27 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2023
3:24 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/25/2023
8:53 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K/A
05/25/2023
8:54 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B5
05/25/2023
4:25 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 424B5
05/25/2023
3:39 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
05/25/2023
3:46 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K/A
05/24/2023
4:29 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/18/2023
8:00 AM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2023
3:21 PM
Biodexa Pharmaceuticals Plc (Filer)
Biodexa Pharmaceuticals (Filer)
Form POS AM
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BDRX) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners